Eagle Pharmaceuticals inc (EGRX) - News Archive

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX), based in Woodcliff Lake, New Jersey, has announced a significant transaction aimed at enhancing its financial standing. On March 31, 2025, the company entered into a royalty...

In a strategic move to safeguard its shareholders and enhance corporate governance, Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX), based in Woodcliff Lake, N.J. announced today that its Board of Directors has adopted a li...

Delisting Process Initiated for Eagle Pharmaceuticals Inc. on Nasdaq: Impact on Shareholders and Stock PriceEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) has recently received a notice from Nasdaq regarding the initiation...

Eagle Pharmaceuticals, a leading entity in the biomedicine space, is set to present supplementary data from their consequential Phase III trial at the revered ASPAN 2024 National Conference, scheduled to be orchestrated...

Woodcliff Lake, N.J., April 12, 2024 - Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) has notified its shareholders that it received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq...

In a notable development in the pharmaceutical industry, Pomerantz Law Firm has announced the filing of a class action lawsuit against Eagle Pharmaceuticals Inc. (NASDAQ: EGRX), leading to potentially significant implic...

Eagle Pharmaceuticals Inc. is a prominent specialty pharmaceutical company known for its focus on developing and commercializing injectable products. However, recent events have led to legal troubles, with a class actio...

Eagle Pharmaceuticals Presents Intriguing Findings on Amisulpride s Efficacy in Postoperative Nausea and Vomiting at PGA ConferenceNew York City, NY - Medical experts from Eagle Pharmaceuticals showcased groundbreaking...